$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 231 | 0 | 5,363 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 231 | 0 | 4,148 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | A | 0.00 | 185 | 0 | 6,129 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 169 | 0 | 4,549 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 169 | 0 | 3,876 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 169 | 0 | 355 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 154 | 0 | 1,658 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 185 | 0 | 371 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | A | 0.00 | 185 | 0 | 5,573 | |
Feb 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 40.49 | 3,846 | 155,710 | 1,649,294 | 1.7 M to 1.6 M (-0.23 %) |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 1,700 | 1,328 | 38,300 | |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 5,000 | 3,905 | 40,000 | |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.25 | 1,700 | 68,421 | 118,866 | 120.6 K to 118.9 K (-1.41 %) |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 1,700 | 1,328 | 120,566 | 118.9 K to 120.6 K (+1.43 %) |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.22 | 5,000 | 201,078 | 118,866 | 123.9 K to 118.9 K (-4.04 %) |
Feb 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 5,000 | 3,905 | 123,866 | 118.9 K to 123.9 K (+4.21 %) |
Feb 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Sell | S | 40.52 | 3,500 | 141,820 | 7,894 | 11.4 K to 7.9 K (-30.72 %) |
Feb 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.63 | 3,846 | 152,406 | 1,653,140 | 1.7 M to 1.7 M (-0.23 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 25 | |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 38.92 | 2,000 | 77,840 | 23,237 | 25.2 K to 23.2 K (-7.92 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 25,237 | 23.2 K to 25.2 K (+8.61 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Grant | A | 36.07 | 416 | 15,005 | 23,237 | 22.8 K to 23.2 K (+1.82 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.38 | 2,064 | 29,670 | 0 | |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.38 | 2,936 | 42,205 | 0 | |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 38.69 | 2,936 | 113,580 | 118,866 | 121.8 K to 118.9 K (-2.41 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.38 | 2,936 | 42,205 | 121,802 | 118.9 K to 121.8 K (+2.47 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 38.69 | 2,064 | 79,846 | 118,866 | 120.9 K to 118.9 K (-1.71 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.38 | 2,064 | 29,670 | 120,930 | 118.9 K to 120.9 K (+1.74 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 36.07 | 416 | 15,005 | 118,866 | 118.5 K to 118.9 K (+0.35 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Corporat ... | Grant | A | 36.07 | 416 | 15,005 | 2,992 | 2.6 K to 3 K (+16.15 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Chief Executive Off ... | Grant | A | 36.07 | 416 | 15,005 | 144,498 | 144.1 K to 144.5 K (+0.29 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 36.07 | 84 | 3,030 | 936,405 | 936.3 K to 936.4 K (+0.01 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 25,936 | |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 38.75 | 500 | 19,375 | 2,597 | 3.1 K to 2.6 K (-16.14 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,097 | 2.6 K to 3.1 K (+19.25 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Grant | A | 36.07 | 416 | 15,005 | 2,597 | 2.2 K to 2.6 K (+19.07 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 36.07 | 416 | 15,005 | 23,121 | 22.7 K to 23.1 K (+1.83 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Grant | A | 36.07 | 416 | 15,005 | 23,010 | 22.6 K to 23 K (+1.84 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Grant | A | 36.07 | 416 | 15,005 | 12,618 | 12.2 K to 12.6 K (+3.41 %) |
Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 2,500 | 29,875 | 14 | |
Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 39.00 | 2,500 | 97,500 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 2,500 | 29,875 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Grant | A | 36.07 | 416 | 15,005 | 15,405 | 15 K to 15.4 K (+2.78 %) |
Jan 23 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.55 | 3,846 | 152,104 | 1,656,986 | 1.7 M to 1.7 M (-0.23 %) |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 5,000 | 3,905 | 45,000 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 41.54 | 5,000 | 207,713 | 118,450 | 123.5 K to 118.5 K (-4.05 %) |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 5,000 | 3,905 | 123,450 | 118.5 K to 123.5 K (+4.22 %) |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 249 | 0 | 5,132 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | A | 0.00 | 218 | 0 | 5,944 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 218 | 0 | 3,917 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 186 | 0 | 4,380 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 186 | 0 | 3,707 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 186 | 0 | 186 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 311 | 0 | 1,504 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 186 | 0 | 186 | |
Jan 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | A | 0.00 | 249 | 0 | 5,388 | |
Jan 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 5,000 | 16,405 | 6,044 | |
Jan 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.00 | 5,000 | 200,000 | 118,450 | 123.5 K to 118.5 K (-4.05 %) |
Jan 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 5,000 | 16,405 | 123,450 | 118.5 K to 123.5 K (+4.22 %) |
Jan 10 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Sell | S | 38.51 | 2,500 | 96,277 | 11,394 | 13.9 K to 11.4 K (-17.99 %) |
Jan 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 38.16 | 3,846 | 146,761 | 1,660,832 | 1.7 M to 1.7 M (-0.23 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 2.66 | 115,479 | 306,712 | 0 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 2.66 | 115,479 | 306,712 | 936,321 | 820.8 K to 936.3 K (+14.07 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 2,025 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 3,000 | 17,190 | 0 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 36.10 | 2,000 | 72,200 | 22,821 | 24.8 K to 22.8 K (-8.06 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 24,821 | 22.8 K to 24.8 K (+8.76 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 3,000 | 17,190 | 22,821 | 19.8 K to 22.8 K (+15.14 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 26,436 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 36.29 | 500 | 18,145 | 2,181 | 2.7 K to 2.2 K (-18.65 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 2,681 | 2.2 K to 2.7 K (+22.93 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 2,500 | 29,875 | 2,514 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 35.89 | 2,500 | 89,725 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 2,500 | 29,875 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
Dec 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 36.79 | 3,846 | 141,510 | 1,664,678 | 1.7 M to 1.7 M (-0.23 %) |
Dec 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Gift | G | 0.00 | 135 | 0 | 19,821 | 20 K to 19.8 K (-0.68 %) |
Dec 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 13.63 | 15,000 | 204,375 | 0 | |
Dec 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 37.90 | 10,000 | 378,972 | 790,842 | 800.8 K to 790.8 K (-1.25 %) |
Dec 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Payment of Exercise | F | 38.10 | 5,364 | 204,368 | 800,842 | 806.2 K to 800.8 K (-0.67 %) |
Dec 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 13.63 | 15,000 | 204,375 | 806,206 | 791.2 K to 806.2 K (+1.90 %) |
Dec 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 38.44 | 3,846 | 147,824 | 1,668,524 | 1.7 M to 1.7 M (-0.23 %) |
Dec 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Sell | S | 39.35 | 2,500 | 98,369 | 2,496 | 5 K to 2.5 K (-50.04 %) |
Dec 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Chief Executive Off ... | Option Exercise | M | 23.00 | 2,173 | 49,979 | 4,347 | |
Dec 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Chief Executive Off ... | Buy | M | 23.00 | 2,173 | 49,979 | 144,082 | 141.9 K to 144.1 K (+1.53 %) |
Dec 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 30,000 | 0 | 791,206 | 821.2 K to 791.2 K (-3.65 %) |
Dec 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 9,000 | 0 | 821,206 | 830.2 K to 821.2 K (-1.08 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 4,025 | |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 39.39 | 2,000 | 78,780 | 19,956 | 22 K to 20 K (-9.11 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 21,956 | 20 K to 22 K (+10.02 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 5,000 | 16,405 | 11,044 | |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.03 | 5,000 | 200,150 | 118,450 | 123.5 K to 118.5 K (-4.05 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 5,000 | 16,405 | 123,450 | 118.5 K to 123.5 K (+4.22 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,000 | 18,850 | 9,800 | |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 39.34 | 1,000 | 39,340 | 22,705 | 23.7 K to 22.7 K (-4.22 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,000 | 18,850 | 23,705 | 22.7 K to 23.7 K (+4.40 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 2,000 | 11,460 | 4,977 | |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 40.01 | 2,000 | 80,020 | 14,989 | 17 K to 15 K (-11.77 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 2,000 | 11,460 | 16,989 | 15 K to 17 K (+13.34 %) |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 1,236 | 14,770 | 5,014 | |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 1,264 | 14,062 | 0 | |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 40.76 | 1,236 | 50,379 | 22,594 | 23.8 K to 22.6 K (-5.19 %) |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 1,236 | 14,770 | 23,830 | 22.6 K to 23.8 K (+5.47 %) |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 40.76 | 1,264 | 51,521 | 22,594 | 23.9 K to 22.6 K (-5.30 %) |
Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 1,264 | 14,062 | 23,858 | 22.6 K to 23.9 K (+5.59 %) |
Nov 29 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 41.32 | 10,000 | 413,188 | 830,206 | 840.2 K to 830.2 K (-1.19 %) |
Nov 28 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 40.77 | 3,846 | 156,820 | 1,672,370 | 1.7 M to 1.7 M (-0.23 %) |
Nov 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Option Exercise | M | 5.73 | 3,000 | 17,190 | 2,875 | |
Nov 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Sell | S | 44.92 | 3,000 | 134,760 | 13,124 | 16.1 K to 13.1 K (-18.61 %) |
Nov 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Buy | M | 5.73 | 3,000 | 17,190 | 16,124 | 13.1 K to 16.1 K (+22.86 %) |
Nov 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 44.78 | 3,846 | 172,205 | 1,676,216 | 1.7 M to 1.7 M (-0.23 %) |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 11.13 | 1,000 | 11,125 | 7,313 | |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 1,000 | 5,730 | 13,273 | |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.00 | 1,000 | 45,000 | 14,989 | 16 K to 15 K (-6.25 %) |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 1,000 | 5,730 | 15,989 | 15 K to 16 K (+6.67 %) |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.00 | 1,000 | 45,000 | 14,989 | 16 K to 15 K (-6.25 %) |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 11.13 | 1,000 | 11,125 | 15,989 | 15 K to 16 K (+6.67 %) |
Nov 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 44.77 | 10,000 | 447,724 | 840,206 | 850.2 K to 840.2 K (-1.18 %) |
Nov 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Sell | S | 44.51 | 3,000 | 133,537 | 4,996 | 8 K to 5 K (-37.52 %) |
Nov 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 43.40 | 10,000 | 433,969 | 850,206 | 860.2 K to 850.2 K (-1.16 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 2,000 | 11,460 | 3,000 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 44.01 | 2,000 | 88,020 | 19,956 | 22 K to 20 K (-9.11 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 2,000 | 11,460 | 21,956 | 20 K to 22 K (+10.02 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 12.00 | 2,907 | 34,884 | 0 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 2,093 | 6,867 | 16,044 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 44.02 | 2,093 | 92,134 | 118,450 | 120.5 K to 118.5 K (-1.74 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 2,093 | 6,867 | 120,543 | 118.5 K to 120.5 K (+1.77 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 44.02 | 2,907 | 127,966 | 118,450 | 121.4 K to 118.5 K (-2.40 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 12.00 | 2,907 | 34,884 | 121,357 | 118.5 K to 121.4 K (+2.45 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,000 | 18,850 | 10,800 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 44.01 | 1,000 | 44,010 | 22,705 | 23.7 K to 22.7 K (-4.22 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,000 | 18,850 | 23,705 | 22.7 K to 23.7 K (+4.40 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 2,000 | 11,460 | 14,273 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 44.02 | 2,000 | 88,040 | 14,989 | 17 K to 15 K (-11.77 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 2,000 | 11,460 | 16,989 | 15 K to 17 K (+13.34 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.90 | 10,000 | 438,957 | 1,680,062 | 1.7 M to 1.7 M (-0.59 %) |
Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 2,500 | 27,813 | 1,264 | |
Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 43.91 | 2,500 | 109,775 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 2,500 | 27,813 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
Oct 31 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 44.15 | 3,846 | 169,802 | 1,690,062 | 1.7 M to 1.7 M (-0.23 %) |
Oct 20 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 46.47 | 10,000 | 464,733 | 860,206 | 870.2 K to 860.2 K (-1.15 %) |
Oct 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Option Exercise | M | 5.73 | 3,000 | 17,190 | 5,875 | |
Oct 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Sell | S | 46.80 | 3,000 | 140,400 | 13,124 | 16.1 K to 13.1 K (-18.61 %) |
Oct 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Buy | M | 5.73 | 3,000 | 17,190 | 16,124 | 13.1 K to 16.1 K (+22.86 %) |
Oct 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 47.08 | 3,846 | 181,060 | 1,693,908 | 1.7 M to 1.7 M (-0.23 %) |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 228 | 0 | 4,883 | |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | A | 0.00 | 200 | 0 | 5,726 | |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 200 | 0 | 3,699 | |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 171 | 0 | 3,521 | |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 171 | 0 | 4,194 | |
Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 285 | 0 | 1,193 |